|
For:
|
Mishra N, Aden K, Blase JI, Baran N, Bordoni D, Tran F, Conrad C, Avalos D, Jaeckel C, Scherer M, Sørensen SB, Overgaard SH, Schulte B, Nikolaus S, Rey G, Gasparoni G, Lyons PA, Schultze JL, Walter J, Andersen V, Banos A, Bertsias G, Beyer M, Boumpas D, Finckh A, Franke A, Georges M, Gu W, Häsler R, Jawhara M, Kenyon A, Kratsch C, Krause R, Lauc G, Mangino M, Natoli G, Ostaszewski M, Pezer M, Raes J, Rahmouni S, Ramos-pamplona M, Reiz B, Rosati E, Sanoudou D, Satagopam V, Schneider R, Schulte-schrepping J, Sidiropoulos P, Smith KGC, Spector T, Vandeputte D, Vieira-silva S, Vojta A, Warnat-herresthal S, Zoldoš V, Dermitzakis ET, Schreiber S, Rosenstiel P; SYSCID Consortium. Longitudinal multi-omics analysis identifies early blood-based predictors of anti-TNF therapy response in inflammatory bowel disease. Genome Med 2022;14. [PMID: 36153599 PMCID: PMC9509553 DOI: 10.1186/s13073-022-01112-z] [Citation(s) in RCA: 20] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2022] [Accepted: 09/02/2022] [Indexed: 11/10/2022] Open |